Fundraising Fox

Rami Daoud

Executive at Affinia Therapeutics

Greater Philadelphia

Find your path to Rami

430 people in our graph share verified history with Rami — schools, employers, funds. One of them is your warm intro.

Sujal PatelunlockedRami: together at University of Maryland (1992–1994)
×2Rami: together at University of Maryland
×3Rami: together at The Wharton School
×2Rami: together at Transform Pharmaceuticals

Executive at Affinia Therapeutics

Intro paths

→

In turn, Rami can intro founders to Affinia Therapeutics's investors below.

Affinia Therapeutics's investors · 8

Atlas VentureCambridge · $500K – $1M checks · since 2025EcoR1 CapitalSan FranciscoEight Roads VenturesMumbai · $5M – $30M checksF-Prime CapitalCambridge · $3M – $10M checks · since 2025GV (Google Ventures)Mountain View · $250K – $50M checksNEA SecondaryTimonium · since 2025New Enterprise Associates (NEA)Menlo Park · $200K – $40M checksTCG CrossoverPalo Alto

Co-founders at Affinia Therapeutics

LV
Luc VandenbergheDirector
ATAaron Tward, M.D., Ph.D.
Aaron Tward, M.D., Ph.D.Scientific Co-Founder
BRBotond Roska, M.D., Ph.D.
Botond Roska, M.D., Ph.D.Scientific Co-Founder
LV
Luk Vandenberghe, Ph.D.Scientific Co-Founder and Adviser, and Board Member

Experience

  1. Affinia TherapeuticsChief Business and Financial Officercurrent2024 — presentWaltham, MA
  2. GeneScience Pharmaceuticals USAPresident2023 — 2024Greater Philadelphia
  3. RD Biotech LLCFounder and CEO2022 — 2023Greater Philadelphia
  4. Amarin CorporationSenior Vice President, Corporate Development2013 — 2021Bridgewater, New Jersey, United States
  5. ACEA BiosciencesExecutive Director/Head, Business Development2012 — 2013Greater San Diego Area
  6. Auxilium PharmaceuticalsSenior Director, Business Development2004 — 2011Greater Philadelphia
  7. Transform PharmaceuticalsManager, Business Development2003 — 2004Greater Boston
  8. Eli Lilly and CompanySenior Associate, Corporate Business Development2001 — 2003Indianapolis, Indiana, United States
  9. Human Genome SciencesSenior Research Associate, R&D1996 — 2000Washington D.C. Metro Area
  10. National Institutes of HealthBiologist1993 — 1995Washington D.C. Metro Area

Skills & more

BiotechnologyStrategyBusiness DevelopmentPharmaceuticalsLife SciencesFinancial AnalysisStrategy DevelopmentDue DiligenceNew Product PlanningAlliance ManagementMedical DevicesContract Negotiations
+12 moreBiopharmaceuticalsPharmaceutical IndustryClinical DevelopmentCross-functional Team LeadershipStrategic AlliancesUrologyManagementBusiness PlanningLifesciencesDrug DevelopmentProduct LaunchMarket Research

From Rami's professional profile.

Frequently asked questions

Who is Rami Daoud?
Executive Officer at Affinia Therapeutics
Where does Rami Daoud work?
Rami Daoud is Executive at Affinia Therapeutics.
Where did Rami Daoud go to school?
Rami Daoud studied at The Wharton School (MBA, Finance & Health Care Management); University of Maryland, Baltimore (UMB) (M.S., Physiology (Neurosciene)); University of Maryland (B.S., Business (Accounting)).

Same school

Also attended The Wharton School2,000

Sarah GuoFounder & General Partner of ConvictionJosh KopelmanFounder and Partner at First Round CapitalAydin SenkutFounder & Managing Partner at FelicisJack AbrahamFounder, CEO & Managing Partner of AtomicKatie RiesterPartner, Head of Investor Relations at Felicis VenturesTrevor OelschigInvestment Team at General Catalyst

+ 1,994 more

Also attended University of Maryland, Baltimore (UMB)8

Jessica SwartzExecutive Advisory Board at NYU Innovation Venture FundRajaniece ThompsonAssistant Director & Grant Manager at Maryland TEDCOBen PortneyPartner at Andreessen HorowitzAlejandro CorvalánMD at Ilico GeneticsVineet RajgarhiaCo-founder at Erg BioCalvin KnowltonDirector, Executive Officer at GalenusRx

+ 2 more

Also attended University of Maryland478

Katrina PagliaChief Legal Officer at Pantera CapitalSujal PatelStrategic Director at Madrona Venture GroupDaniel DemmerInvestor at OpenView Venture PartnersDan RochkindCFO at Lerer HippeauAaron EpsteinGeneral Partner at Y CombinatorKevin NiechenInvestment Team at 8VC

+ 472 more

Shared employers

Also worked at Amarin Corporation6

Michael FarrellHead of Portfolio Company Operations at Deerfield Management CompanyErin EnrightManaging Partner, Prettybrook Partners LLC at The 98Paul VarkiChief Legal Officer at Avalo TherapeuticsCraig B. GranowitzExecutive Officer at Lexicon PharmaceuticalsLisa DeFrancescoExecutive Officer at Lexicon PharmaceuticalsSteven KingPresident – US Operations at Immersive Labz

Also worked at Auxilium Pharmaceuticals3

Jane H. HollingsworthManaging Partner at Militia Hill VenturesAshley IvanowiczSenior Vice President, Human Resources at Avalo TherapeuticsAl AltomariExecutive Officer, Director at Agile Therapeutics

Also worked at Transform Pharmaceuticals4

Erin MooreInvestor at Third Rock VenturesJeb KeiperInvestor at Third Rock VenturesOrn AlmarssonExecutive Officer, Director, Promoter at AxelyfEric GornsteinExecutive Officer, Director at Pearl Diagnostics

Also worked at Eli Lilly and Company189

David MollerInvestor at Third Rock VenturesJesper GromadaInvestor at Third Rock VenturesMark LevinRetired Founding Partner at Third Rock VenturesNatalie FurneyGlobal General Counsel at Takeda VenturesRhonda PachecoPresident, U.S. Business Unit and U.S. Country Head at Takeda VenturesCarlos PayaVenture Partner at Ysios Capital

+ 183 more